A detailed history of E Rn Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, E Rn Financial, LLC holds 2,482 shares of MRK stock, worth $312,359. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,482
Previous 2,482 -0.0%
Holding current value
$312,359
Previous $270,000 21.11%
% of portfolio
0.06%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$100.18 - $109.02 $5,610 - $6,105
-56 Reduced 2.21%
2,482 $270,000
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $5,765 - $6,402
56 Added 2.26%
2,538 $261,000
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $10,191 - $11,371
-99 Reduced 3.84%
2,482 $264,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $349 - $448
4 Added 0.16%
2,581 $286,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $19,526 - $21,935
231 Added 9.85%
2,577 $222,000
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $195,867 - $222,025
2,346 New
2,346 $214,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track E Rn Financial, LLC Portfolio

Follow E Rn Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Rn Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on E Rn Financial, LLC with notifications on news.